Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.

Certain drugs that block specific enzymes can help treat prostate diseases.

Alopecia in animals can be hereditary, congenital, or acquired, with treatments and outcomes varying widely.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

A hormone linked to collagen helps hair grow back in mice after chemotherapy, and may also prevent bone loss.

The spiny mouse is a unique menstruating rodent that can help us understand menstruation and reproductive disorders.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

Growth hormone levels affect hair growth and loss, with too much causing excess hair and too little leading to hair loss.

The dog's skin condition improved after removing a tumor that was causing hormone imbalances.

Ovarian vein sampling helped diagnose rare ovarian tumors causing high testosterone, and surgery to remove the tumors lowered the testosterone levels.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Sulforaphane from broccoli may help treat certain cancers, hormone issues, and hair loss.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

Treatments for hair loss include estrogen therapy and special shampoos.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

Hormone imbalances from endocrine diseases can cause various skin conditions that help diagnose and treat these diseases early.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Both estrogens and androgens are important for health in both males and females.

Menopause affects hair and skin; more research needed for treatment.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.